138 related articles for article (PubMed ID: 7666058)
1. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies.
Wolf HK; Birkholz T; Wellmer J; Blümcke I; Pietsch T; Wiestler OD
J Neuropathol Exp Neurol; 1995 Sep; 54(5):689-97. PubMed ID: 7666058
[TBL] [Abstract][Full Text] [Related]
2. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies.
Wolf HK; Wellmer J; Müller MB; Wiestler OD; Hufnagel A; Pietsch T
J Neuropathol Exp Neurol; 1995 Mar; 54(2):245-54. PubMed ID: 7876892
[TBL] [Abstract][Full Text] [Related]
3. Perilesional neurochemical changes in focal epilepsies.
Wolf HK; Roos D; Blümcke I; Pietsch T; Wiestler OD
Acta Neuropathol; 1996; 91(4):376-84. PubMed ID: 8928614
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy.
Deb P; Sharma MC; Tripathi M; Sarat Chandra P; Gupta A; Sarkar C
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):461-8. PubMed ID: 16972880
[TBL] [Abstract][Full Text] [Related]
5. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor.
Aronica E; Leenstra S; Jansen GH; van Veelen CW; Yankaya B; Troost D
Acta Neuropathol; 2001 Apr; 101(4):383-92. PubMed ID: 11355310
[TBL] [Abstract][Full Text] [Related]
6. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies.
Blümcke I; Wiestler OD
J Neuropathol Exp Neurol; 2002 Jul; 61(7):575-84. PubMed ID: 12125736
[TBL] [Abstract][Full Text] [Related]
7. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
Schick V; Majores M; Koch A; Elger CE; Schramm J; Urbach H; Becker AJ
Epilepsia; 2007; 48 Suppl 5():65-73. PubMed ID: 17910583
[TBL] [Abstract][Full Text] [Related]
8. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors.
Blümcke I; Löbach M; Wolf HK; Wiestler OD
Microsc Res Tech; 1999 Jul; 46(1):53-8. PubMed ID: 10402272
[TBL] [Abstract][Full Text] [Related]
9. [Morphological findings in temporal lobe epilepsy: experience with 216 consecutive surgical specimens].
Wolf HK; Zentner J; Hufnagel A; Campos MG; Schramm J; Elger CE; Wiestler OD
Verh Dtsch Ges Pathol; 1994; 78():438-42. PubMed ID: 7534018
[TBL] [Abstract][Full Text] [Related]
10. [Neuropathologic findings in chronic epilepsy].
Wolf HK; Wiestler OD
Laryngorhinootologie; 1995 Feb; 74(2):127-9. PubMed ID: 7710607
[TBL] [Abstract][Full Text] [Related]
11. Molecular neuropathology of epilepsy-associated glioneuronal malformations.
Becker AJ; Blümcke I; Urbach H; Hans V; Majores M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):99-108. PubMed ID: 16462201
[TBL] [Abstract][Full Text] [Related]
12. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors.
Wolf HK; Buslei R; Blümcke I; Wiestler OD; Pietsch T
Acta Neuropathol; 1997 Nov; 94(5):436-43. PubMed ID: 9386775
[TBL] [Abstract][Full Text] [Related]
13. Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children.
Giulioni M; Galassi E; Zucchelli M; Volpi L
J Neurosurg; 2005 Apr; 102(3 Suppl):288-93. PubMed ID: 15881752
[TBL] [Abstract][Full Text] [Related]
14. Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors.
Fassunke J; Majores M; Tresch A; Niehusmann P; Grote A; Schoch S; Becker AJ
Brain; 2008 Nov; 131(Pt 11):3034-50. PubMed ID: 18819986
[TBL] [Abstract][Full Text] [Related]
15. Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions.
Schick V; Majores M; Fassunke J; Engels G; Simon M; Elger CE; Becker AJ
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):152-62. PubMed ID: 17359356
[TBL] [Abstract][Full Text] [Related]
16. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy.
Aronica E; Yankaya B; Jansen GH; Leenstra S; van Veelen CW; Gorter JA; Troost D
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):223-37. PubMed ID: 11489142
[TBL] [Abstract][Full Text] [Related]
17. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci.
Ferrer I; Oliver B; Russi A; Casas R; Rivera R
J Neurol Sci; 1994 May; 123(1-2):18-25. PubMed ID: 8064311
[TBL] [Abstract][Full Text] [Related]
18. The human temporal cortex: characterization of neurons expressing nitric oxide synthase, neuropeptides and calcium-binding proteins, and their glutamate receptor subunit profiles.
González-Albo MC; Elston GN; DeFelipe J
Cereb Cortex; 2001 Dec; 11(12):1170-81. PubMed ID: 11709488
[TBL] [Abstract][Full Text] [Related]
19. Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions.
Majores M; Schick V; Engels G; Fassunke J; Elger CE; Schramm J; Blümcke I; Becker AJ
Acta Neuropathol; 2005 Dec; 110(6):537-46. PubMed ID: 16231158
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of interneuron distribution between neocortex and basal ganglia: consideration of epileptogenesis of focal cortical dysplasia.
Sakakibara T; Sukigara S; Otsuki T; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sato N; Nakagawa E; Sugai K; Sasaki M; Goto Y; Itoh M
J Neurol Sci; 2012 Dec; 323(1-2):128-33. PubMed ID: 22989610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
